Patent · US Active

Benzoimidazole compounds and uses thereof

US8530467B2 · kind B2 · utility

3Cited by

1References

29Claims

0Family size

Assignee

Neomed Institute · CA

Inventors

Louis-David Cantin · Hamden, US
Xuehong Luo · Montréal, CA
Miroslaw Tomaszewski · Mont-Laurier, CA

Key dates

Filing date	May 16, 2012
Grant date	Sep 10, 2013
Priority date	—
Expiry date	May 16, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D265/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.